Mankind Pharma shares surged as much as 8% on Tuesday, Oct. 27, after the pharmaceutical company reported strong earnings growth for the September quarter, supported by higher revenue, improved operating margins, and growth across its domestic and international businesses.
Around 9:58 a.m., the stock is trading at Rs 2,492.10, up 7.85% on the National Stock Exchange, against its previous close at Rs 2,312.
Mankind Pharma Q2 Results: Key Highlights
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
Mankind Pharma reported a 39.1% YoY rise in consolidated net profit to Rs 711 crore for the September quarter, compared with Rs 512 crore in the corresponding quarter last year.
Revenue from operations increased 17.3% to Rs 4,338 crore from Rs 3,697 crore a year earlier. Ebitda rose 27.1% to Rs 1,171 crore, against Rs 921 crore in the year-ago quarter.
The Ebitda margin expanded by 210 basis points to 27%, from 24.9% in the corresponding quarter last year. The improvement in profitability outpaced revenue growth during the period.
Also Read: Mankind Pharma Q2 Results: Net Profit Jumps 39% To Rs 711 Crore, Margin Expands
Domestic Business And Exports Support Growth
Mankind Pharma's domestic pharmaceutical revenue, excluding consumer healthcare, rose 15.9% to Rs 3,428 crore, while exports grew 32.7% to Rs 681 crore. Cardiac and anti-diabetes therapies grew 18.7% and 15.8%, respectively.
Consumer healthcare revenue increased 1.2% to Rs 229 crore, while online and modern trade channels grew 55%, raising their combined share to 18% from 12% a year earlier.
Mankind Pharma Stock Price Performance
The pharma stock has been delivering positive returns over the long term, and in 2026 so far, the stock has offered a 14.7% return.
During the past week itself, the stock gained over 10.2% and is currently trading at a price-to-earnings multiple of 42.2 times, with a market cap of Rs 1,02,703.7 crore.
Also Read: Mankind Pharma Q2 Review: Jefferies, Kotak Retain Buy After Strong Earnings. Check Target Prices
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
